Markets:

Overview

News

Currencies

International

Treasuries

Provention Bio, Inc. - Common Stock (NQ:PRVB)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 26, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Provention Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows ↗

March 13, 2023

After the market mayhem seen last week, some semblance of normalcy could return to Wall Street, thanks to the government’s move to assuage concerns in response to the banking crisis.

Via Benzinga

Why Shares of MacroGenics Jumped Thursday ↗

March 09, 2023

The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy.

Via The Motley Fool

2 Beaten-Down Stocks That Might Be too Cheap to Ignore ↗

February 22, 2023

There is an argument for hitting the buy button, but it's important to consider the potential risks too.

Via The Motley Fool

IAC To Rally Around 40%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

February 15, 2023

Mizuho boosted the price target for SoFi Technologies, Inc. (NASDAQ: SOFI) from $6 to $9.. Goldman Sachs analyst Emily Chieng maintained a Sell rating on the stock. SoFi Technologies shares fell 0.6%...

Via Benzinga

Analyst Expectations for Provention Bio's Future ↗

February 15, 2023

Via Benzinga

Why Shares of Provention Bio Went Up 30.3% in November ↗

December 05, 2022

The company got approval for its lead type 1 diabetes therapy.

Via The Motley Fool

What 5 Analyst Ratings Have To Say About Provention Bio ↗

November 18, 2022

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 29, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 23, 2022

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 12, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Is This Biotech Stock a Buy Following a Landmark Approval? ↗

December 04, 2022

You may not want to be too quick to pull the trigger.

Via The Motley Fool

Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors ↗

December 02, 2022

Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%.

Via Benzinga

Provention Bio (PRVB) Stock Falls Despite FDA Approval ↗

November 18, 2022

Provention Bio is celebrating a milestone medical moment. Yet, PRVB stock is falling because an important drug may be overpriced.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Friday ↗

November 25, 2022

On Friday, 68 companies reached new 52-week highs.

Via Benzinga

ConocoPhillips To Plunge Over 11%? Plus This Analyst Slashes PT On LiveOne By 25% ↗

November 21, 2022

Societe Generale boosted the price target on ConocoPhillips (NYSE: COP) from $106 to $114. ConocoPhillips shares fell 2% to close at $128.59 on Friday.

Via Benzinga

Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday ↗

November 23, 2022

Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 18, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

TSLA Stock Alert: Tesla Recalls 30,000 EVs for Airbag Issue ↗

November 18, 2022

Tesla (TSLA) stock is in the news Friday as investors react to the electric vehicle company (EV) recalling 30,000 units due to airbag issues.

Via InvestorPlace

Why Did Ticketmaster Cancel Taylor Swift Ticket Sales? ↗

November 18, 2022

Ticketmaster is caught up in drama after it had to cancel sales of Taylor Swift tickets due to problems with its website.

Via InvestorPlace

Delta Apparel, Farfetch, American Software And Some Other Big Stocks Moving Lower On Friday ↗

November 18, 2022

U.S. stocks traded mixed, with the Dow Jones gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Three Months Wait Time For Twitter Blue Mark Verification, Zuckerberg's WhatsApp And Metaverse Plans, China's COVID-19 Measures Hurt Alibaba's Biggest Event: Top Stories Friday, Nov. 18 ↗

November 18, 2022

Reuters

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 18, 2022

Via Benzinga

Why Farfetch Shares Are Trading Lower; Here Are 26 Stocks Moving Premarket ↗

November 18, 2022

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares rose 58.1% to $2.45 in pre-market trading. PaxMedica entered into committed equity investment agreement for up to $20 million with Lincoln Park Capital.

Via Benzinga

First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles ↗

November 18, 2022

Via Benzinga

Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 18, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Tesla, Amazon, Provention Bio, Polestar, Palo Alto Networks: Musk's Court Case, Job Cuts, Earnings Pull Investor Eyeballs ↗

November 17, 2022

Major Wall Street indices closed in the red and bond yields rose on Thursday as investors and traders digested comments from a Federal Reserve official in the context of potential interest rate hikes...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 17, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Miniso Group, Monday.com And Other Big Gainers From Monday ↗

November 15, 2022

U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Is Provention Biosciences (PRVB) Stock Up 25% Today? ↗

November 03, 2022

Provention Biosciences shares are trending after reporting earnings. PRVB stock is also up 25% on hopes of FDA approval for teplizumab.

Via InvestorPlace

Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday ↗

November 04, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Provention Bio, Inc. - Common Stock (NQ:PRVB)

Headline News about Provention Bio, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today